Passage Bio Inc. (NASDAQ: PASG)
$0.5310
-0.0050 ( -1.67% ) 70.9K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.5310
Previous close
$0.5360
Volume
70.9K
Market cap
$32.89M
Day range
$0.5230 - $0.5700
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 74 | Nov 13, 2024 |
| 8-k | 8K-related | 46 | Nov 13, 2024 |
| 8-k | 8K-related | 34 | Oct 24, 2024 |
| 4 | Insider transactions | 1 | Oct 02, 2024 |
| 4 | Insider transactions | 1 | Oct 02, 2024 |
| 3 | Insider transactions | 2 | Oct 02, 2024 |
| 4 | Insider transactions | 1 | Sep 23, 2024 |
| 4 | Insider transactions | 1 | Sep 18, 2024 |
| 8-k | 8K-related | 47 | Sep 16, 2024 |
| 8-k | 8K-related | 13 | Sep 10, 2024 |